Oridonin Induces Apoptosis in Esophageal Squamous Cell Carcinoma by Inhibiting Cytoskeletal Protein LASP1 and PDLIM1
Molecules · 2023
DOI: 10.3390/molecules28020805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Xiaojun Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences & Border Biomedical Research Center, University of Texas at El Paso, El Paso, TX 79968, USA. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, LIM Domain Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMHD NIH HHS, National Institutes on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health (NIH), a Project of Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences.
Abstract (Originalsprache)
Esophageal squamous cell carcinoma is a severe malignancy for its high mortality and poor prognosis. Mainstay chemotherapies cause serious side effects for their ways of inducing cell death. Oridonin is the main bioactive constituent from natural plants that has anticancer ability and weak side effects. The proteomics method is efficient to understand the anticancer mechanism. However, proteins identified by proteomics aimed at understanding oridonin’s anticancer mechanism is seldom overlapped by different groups. This study used proteomics based on two-dimensional electrophoresis sodium dodecyl sulfate-polyacrylamide gel electrophoresis (2-DE SDS-PAGE) integrated with mass spectrometry and Gene Set Enrichment Analysis (GSEA) to understand the anticancer mechanism of oridonin on esophageal squamous cell carcinoma (ESCC). The results showed that oridonin induced ESCC cell death via apoptosis by decreasing the protein expression of LASP1 and PDLIM1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences & Border Biomedical Research Center, University of Texas at El Paso, El Paso, TX 79968, USA.
- Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, China.
Förderung
- NIMHD NIH HHS
- National Institutes on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health (NIH)
- a Project of Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences
Zitieren
APA
Zhang, X., Xing, M., Ma, Y., Zhang, Z., Qiu, C., Wang, X., Zhao, Z., Ji, Z., & Zhang, J. Y. (2023). Oridonin Induces Apoptosis in Esophageal Squamous Cell Carcinoma by Inhibiting Cytoskeletal Protein LASP1 and PDLIM1. Molecules. https://doi.org/10.3390/molecules28020805
Vancouver
Zhang X, Xing M, Ma Y, Zhang Z, Qiu C, Wang X, et al. Oridonin Induces Apoptosis in Esophageal Squamous Cell Carcinoma by Inhibiting Cytoskeletal Protein LASP1 and PDLIM1. Molecules. 2023. doi:10.3390/molecules28020805
BibTeX
@article{Zhang2023,
author = {Zhang, Xiaojun and Xing, Mengtao and Ma, Yangcheng and Zhang, Zhuangli and Qiu, Cuipeng and Wang, Xiao and Zhao, Zhihong and Ji, Zhenyu and Zhang, Jian-Ying},
title = {Oridonin Induces Apoptosis in Esophageal Squamous Cell Carcinoma by Inhibiting Cytoskeletal Protein LASP1 and PDLIM1},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28020805}
}
EUVIMED